Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Bone Research

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1618296

Transcriptomics and network pharmacology reveal the potential mechanism related to integrated stress response in the treatment of osteoporosis by Jiawei Shentong Zhuyu Decoction and verified by RT-qPCR

Provisionally accepted
Jie  ZhaoJie Zhao1TingTing  ZhangTingTing Zhang2Pengbo  HanPengbo Han1Zhu  LiuZhu Liu1Hongli  ZhangHongli Zhang1Fangqin  LiFangqin Li1Gang  HanGang Han1*
  • 1The Second Afliated Hospital of Xi’an Medical College, Xi’an 710000, Shaanxi, China, Xi’an, China
  • 2Xi'an Fifth Hospital, Xi'an, Shaanxi, China

The final, formatted version of the article will be published soon.

Background: Osteoporosis (OP) is a systemic skeletal disorder. The molecular mechanisms underlying the effects of Jia Wei Shentong Zhuyu Decoction (JWSTZYD) and the integrated stress response (ISR) in OP remain unclear. This study aims to elucidate the mechanisms by which JWSTZYD and ISR contribute to OP. Methods: Potential drug target genes for JWSTZYD and OP-related datasets were sourced from the Gene Expression Omnibus (GEO) and Traditional Chinese Medicine Systems Pharmacology (TCMSP) databases. Differentially expressed genes (DEGs) in OP were identified by analyzing transcriptome data. Candidate genes were selected by intersecting target genes, DEGs, and ISR-related genes (ISR-RGs), with further screening based on expression levels in OP and control samples. The potential mechanisms of these biomarkers in OP were explored through gene set enrichment analysis (GSEA), immune infiltration analysis, molecular regulatory networks, and molecular docking. Expression levels of biomarkers were validated using clinical samples. Results: COL4A6 and NKX3-1 were identified as biomarkers associated with ISR in JWSTZYD treatment of OP. These biomarkers were significantly enriched in 22 and 23 pathways, respectively. Immune infiltration analysis revealed 10 differentially abundant immune cell types between OP and control. Further analysis showed that 16 transcription factors (TFs), 26 miRNAs, and 342 lncRNAs had potential interactions with the biomarkers. TFs such as FOXC1, USF2, NFYA, SRF, and NFIC were co-regulated by the biomarkers. Quercetin was identified as a drug that co-acted with these biomarkers, demonstrating strong binding affinity with both COL4A6 and NKX3-1, with binding energies of -6.3 kcal/mol and -15.7 kcal/mol, respectively. Experimental validation confirmed that the biomarkers were expressed at levels consistent with those predicted. Conclusion: This study identified COL4A6 and NKX3-1 as key biomarkers, providing new insights into the mechanisms associated with ISR in the treatment of OP using JWSTZYD.

Keywords: Osteoporosis1, Jiawei shentong zhuyu decoction2, Integrated stress response3, COL4A6/NKX3-1 4, network pharmacology5, Quercetin6

Received: 25 Apr 2025; Accepted: 02 Oct 2025.

Copyright: © 2025 Zhao, Zhang, Han, Liu, Zhang, Li and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Gang Han, 13389205229@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.